Article
Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie - 1 Feb 2015
Hata Masayuki, Tsujikawa Akitaka, Miyake Masahiro, Yamashiro Kenji, Ooto Sotaro, Oishi Akio, Nakata Isao, Takahashi Ayako, Yoshimura Nagahisa
Abstract excerpt
PURPOSE: To investigate the 2-year outcomes of photodynamic therapy (PDT) combined with intravitreal injections of ranibizumab for polypoidal choroidal vasculopathy (PCV). METHODS: Ninety-five eyes with subfoveal PCV treated with combined therapy were followed for ≥24 months. The association between visual outcomes and single nucleotide polymorphisms in ARMS2 A69S and CFH I62V genes were examined without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
